Mediclinic International

Mediclinic Group
Company type	Private
Traded as	LSE: MDC; JSE: MEI;
Industry	Hospital management
Founded	October 3, 1983; 40 years ago
Headquarters	Stellenbosch, South Africa
Key people	Dr Ronnie van der Merwe (CEO)
Revenue	£3,233 million (2022)
Operating income	£280 million (2022)
Net income	£170 million (2022)
Number of employees	34,278 (2022)
Website	www.mediclinic.com

Mediclinic Group, founded in 1983, is an international private hospital group with operations in South Africa, Namibia, Switzerland and the United Arab Emirates. The Group's head office is based in Stellenbosch, South Africa. It has been listed on the JSE, the South African securities exchange, since 1986. It was listed on the London Stock Exchange until it was acquired by a South African consortium which included Remgro and Mediterranean Shipping Company in May 2023.

History

Mediclinic was founded in 1983 in Stellenbosch, South Africa when Dr Edwin Hertzog, was commissioned by the then Rembrandt Group (now Remgro Group) to undertake a feasibility study on how profitable private hospitals could be. Three years later Mediclinic, running four hospitals in commission and three hospitals under construction, listed on the JSE, the South African stock exchange in 1986.^[2]

In 2006, Mediclinic reached agreement to acquire a controlling interest in Emirates Healthcare in Dubai, United Arab Emirates, which then owned one hospital, the rights to develop two further hospitals in the Dubai Healthcare City and five clinics.^[3]

Mediclinic acquired Hirslanden, the largest private hospital group in Switzerland, for SF2.54bn in 2007.^[3]

In June 2015, Mediclinic then acquired a 29.9% interest in Spire Healthcare, a UK-based private healthcare group.^[4]

Mediclinic announced a reverse merger of Al Noor Hospitals in October 2015.^[5] The former Mediclinic shareholders owned up to 93% of the combined business on completion.^[5] The merger was completed on 15 February 2016.^[6]

The healthcare group officially started trading on the London Stock Exchange on 16 February 2016.^[7]

The founder stepped down in 2020 and Dame Inga Beale took over as Chair of the company.^[8]

The South African arm of Mediclinic was criticised in 2021 when it emerged that controversial doctor Wouter Basson was working at one of its Western Cape facilities.^[9]

In August 2022, the company accepted a takeover offer worth £3.7 billion from a South African consortium which included Remgro and Mediterranean Shipping Company.^[10] In May 2023, the company confirmed that the South African Reserve Bank had approved the transaction, so allowing it to complete.^[11]